1. Acha-Orbea, H., Shakov, A. N., Scarpellino, L., Kolb, E., Muller, V., Vessaz-Shaw, A., Fuchs, R., Blöchinger, K., Rollini, P., Billotte, J., Sarafidou, M., Robson MacDonald, H., and Diggelmann, H., 1991, Clonal deletion of Vβ14-bearing T cells in mice transgenic for ammary tumour virus, Nature 350:207–211.
2. Achong, B. G., and Epstein, M. M., 1978, Preliminary seroepidemiological studies on the human syncytial virus in West Africa, J. Gen. Virol. 40:175–181.
3. Achong, G., Mansell, P. W. A., Epstein, M.A., and Clifford, P., 1971, An unusual virus in cultures from a human nasopharyngeal carcinoma, J. Natl. Cancer Inst. 42:299–307.
4. Aguzzi, A., 1993, The foamy virus family: Molecular biology, epidemiology and neuropathology, Biochim. Biophys. Acta 1155:1–24.
5. Aguzzi, A., Bothe, K., Anhauser, I., Horak, I., Rethwilm, A., and Wagner, E. F., 1992a, Expression of human foamy virus is differentially regulated during development in transgenic mice, New Biol. 4:1–13.